肝硬化
肝细胞癌
脂肪性肝炎
纤维化
医学
肝星状细胞
慢性肝病
酒精性肝病
肝纤维化
病理
人口
内科学
脂肪肝
生物信息学
肝病
癌症研究
疾病
生物
环境卫生
作者
Sara Crespo Yanguas,Bruno Cogliati,Joost Willebrords,Michaël Maes,Isabelle Colle,Bert Van Den Bossche,Cláudia P. Oliveira,Wellington Andraus,Venâncio Avancini Ferreira Alves,Isabelle Leclercq,Mathieu Vinken
标识
DOI:10.1007/s00204-015-1543-4
摘要
Hepatic fibrosis is a wound healing response to insults and as such affects the entire world population. In industrialized countries, the main causes of liver fibrosis include alcohol abuse, chronic hepatitis virus infection and non-alcoholic steatohepatitis. A central event in liver fibrosis is the activation of hepatic stellate cells, which is triggered by a plethora of signaling pathways. Liver fibrosis can progress into more severe stages, known as cirrhosis, when liver acini are substituted by nodules, and further to hepatocellular carcinoma. Considerable efforts are currently devoted to liver fibrosis research, not only with the goal of further elucidating the molecular mechanisms that drive this disease, but equally in view of establishing effective diagnostic and therapeutic strategies. The present paper provides a state-of-the-art overview of in vivo and in vitro models used in the field of experimental liver fibrosis research.
科研通智能强力驱动
Strongly Powered by AbleSci AI